Comparative tolerability of sedative agents in head-injured adults.

Abstract

Sedative agents are widely used in the management of patients with head injury. These drugs can facilitate assisted ventilation and may provide useful reductions in cerebral oxygen demand. However, they may compromise cerebral oxygen delivery via their cardiovascular effects. In addition, individual sedative agents have specific and sometimes serious adverse effects. This review focuses on the different classes of sedative agents used in head injury, with a discussion of their role in the context of clinical pathophysiology. While there is no sedative that has all the desirable characteristics for an agent in this clinical setting, careful titration of dose, combination of agents, and a clear understanding of the pathophysiology and pharmacology of these agents will allow safe sedative administration in head injury.

• Authors: Susan C Urwin, David K Menon
• Journal: Drug safety (Drug Saf) Vol. 27 Issue 2 Pg. 107-33 ( 2004) ISSN: 0114-5916 [Print] New Zealand
• PMID: 14717622 (Publication Type: Journal Article, Review)

Chemical References

• Antipsychotic Agents
• Barbiturates
• Hypnotics and Sedatives
• Narcotics
• Benzodiazepines
• Ketamine
• Propofol
• Etomidate

Topics

• Antipsychotic Agents (adverse effects, pharmacology)
• Barbiturates (adverse effects, pharmacology)
• Benzodiazepines (adverse effects, pharmacology)
• Craniocerebral Trauma (drug therapy, physiopathology)
• Drug Tolerance
• Etomidate (adverse effects, pharmacology)
• Humans
• Hypnotics and Sedatives (adverse effects, classification, pharmacology)
• Ketamine (adverse effects, pharmacology)
• Narcotics (adverse effects, pharmacology)
• Propofol (adverse effects, pharmacology, therapeutic use)